Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-17

Clinical Trial Update: Impact of Text Messaging in the Management of Non-alcoholic Fatty Liver Disease [NA]

View source ↗

Summary

A completed clinical trial evaluating whether a text messaging program can aid in the management of non-alcoholic fatty liver disease and nonalcoholic steatohep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ashwani Singal,MD | Conditions: NAFLD and NASH | NA | Status: COMPLETED